- Home
- INBS vs SLXN Comparison
INBS vs SLXN Comparison
Compare INBS & SLXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBS
- SLXN
- Stock Information
- Founded
- INBS 2016
- SLXN 2008
- Country
- INBS United States
- SLXN Israel
- Employees
- INBS N/A
- SLXN N/A
- Industry
- INBS Medical Specialities
- SLXN
- Sector
- INBS Health Care
- SLXN
- Exchange
- INBS Nasdaq
- SLXN NYSE
- Market Cap
- INBS 6.3M
- SLXN 5.2M
- IPO Year
- INBS N/A
- SLXN N/A
- Fundamental
- Price
- INBS $1.30
- SLXN $2.44
- Analyst Decision
- INBS
- SLXN Strong Buy
- Analyst Count
- INBS 0
- SLXN 1
- Target Price
- INBS N/A
- SLXN $1.00
- AVG Volume (30 Days)
- INBS 132.7K
- SLXN 1.1M
- Earning Date
- INBS 02-07-2025
- SLXN 02-21-2025
- Dividend Yield
- INBS N/A
- SLXN N/A
- EPS Growth
- INBS N/A
- SLXN N/A
- EPS
- INBS N/A
- SLXN N/A
- Revenue
- INBS $3,187,974.00
- SLXN N/A
- Revenue This Year
- INBS $280.88
- SLXN N/A
- Revenue Next Year
- INBS $126.26
- SLXN N/A
- P/E Ratio
- INBS N/A
- SLXN N/A
- Revenue Growth
- INBS 55.29
- SLXN N/A
- 52 Week Low
- INBS $1.00
- SLXN $0.21
- 52 Week High
- INBS $11.70
- SLXN $13.56
- Technical
- Relative Strength Index (RSI)
- INBS 36.48
- SLXN N/A
- Support Level
- INBS $1.20
- SLXN N/A
- Resistance Level
- INBS $1.69
- SLXN N/A
- Average True Range (ATR)
- INBS 0.12
- SLXN 0.00
- MACD
- INBS -0.04
- SLXN 0.00
- Stochastic Oscillator
- INBS 19.61
- SLXN 0.00
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).
About SLXN BIOMOTION SCIENCES
Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.